Blog

[printfriendly]
  • Sep 1, 2011

    NeurogesX Submits Supplemental new Drug Application for Qutenza (R) 8% Patch for HIV-Associated Peripheral Neuropathy

    Biopharmaceutical company, NeurogesX, announced it submitted a supplemental new drug to the US FDA seeking to expand the label to include an application for the management of pain due to…
  • Sep 1, 2011

    Olive Leaf Extract May Help Fight Early-Diabetes Nerve Damage, Pain

    At Kerman University of Medical Sciences in Kerman, Iran, researchers investigated the possible effects of olive leaf extract on in vitro and in vivo models of diabetic peripheral neuropathy. Their…
  • Sep 1, 2011

    U of M Earns $3 Million Grant to Develop Treatment for Nerve Damage

    Univeristy of Michigan neurologist, David Fink, MD, leads the team studying treatment for nerve damage related to diabetes and chemotherapy. They will join Diamyd Inc. in a project funded by…
  • Sep 1, 2011

    Diamyd Gets $3M to Develop Treatment for Chemotherapy-Induced PN

    Diamyd Medical and the University of Michigan have been awarded a $3M three-year NIH grant to develop a product for use in preventing chemo-induced neuropathy. The product could be administered…
  • Sep 1, 2011

    Conquer Cancer Foundation Presents Award to Dr. Schneider for his Research in Breast Cancer Patients

    Dr. Bryan Schneider, MD, associate professor of medicine at Indiana University School of Medicine, was announced as the recipient of a $450,000 grant to further his research on the relationship…
  • Sep 1, 2011

    Marijuana Extract Might Help Prevent Chemotherapy-Related Nerve Pain

    Cannabidiol – a compound derived from marijuana – may be a promising new treatment to prevent the development of painful neuropathy in patients receiving the chemotherapy drug paclitaxel. These results…
  • Sep 1, 2011

    Chemotherapy-Induced Peripheral Neuropathy: A Debilitating Effect of Cancer

    Colleen Erb, MSN, ACNP-BC, AOCNP, from Fox Chase Cancer Center writes about the debilitating effects of cancer treatments for patients – specifically peripheral neuropathy. Her article is in-depth and loaded…
  • Aug 1, 2011

    Rosiglitazone Investigated for Neuropathic Pain

    The diabetes drug rosiglitazone (Avandia) is now being explored as a pain medication. The drug was initially controversial with some experts wanting to banish it and others wanting very tight…